BioCryst Pharmaceuticals
BCRX
#4930
Rank
ยฃ1.45 B
Marketcap
ยฃ5.67
Share price
-1.17%
Change (1 day)
3.51%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): -ยฃ1.01

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ1.07. In 2022 the company made an earnings per share (EPS) of -ยฃ0.99 a decrease over its 2021 EPS that were of -ยฃ0.77.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ1.011.99%
2022-ยฃ0.9929.13%
2021-ยฃ0.77-4.63%
2020-ยฃ0.8110.2%
2019-ยฃ0.730%
2018-ยฃ0.7325.64%
2017-ยฃ0.584%
2016-ยฃ0.5627.12%
2015-ยฃ0.44-13.24%
2014-ยฃ0.5123.64%
2013-ยฃ0.41-30.38%
2012-ยฃ0.59-37.3%
2011-ยฃ0.9465.79%
2010-ยฃ0.57117.14%
2009-ยฃ0.26-46.15%
2008-ยฃ0.48-26.97%
2007-ยฃ0.66-40.67%
2006-ยฃ1.1248.51%
2005-ยฃ0.751%
2004-ยฃ0.7538.89%
2003-ยฃ0.54-25%
2002-ยฃ0.72231.03%
2001-ยฃ0.22-56.72%
2000-ยฃ0.5091.43%
1999-ยฃ0.262.94%
1998-ยฃ0.25-55.84%
1997-ยฃ0.5711.59%
1996-ยฃ0.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-ยฃ2.31 115.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ2.15-299.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-ยฃ1.96 82.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-ยฃ0.15-86.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-ยฃ1.13 5.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ3.24 202.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-ยฃ0.33-69.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-ยฃ2.37 120.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-ยฃ2.56 138.89%๐Ÿ‡บ๐Ÿ‡ธ USA